Cough during flexible bronchoscopy in patients undergoing diagnostic or therapeutic bronchoscopy. Bronchoscopy Cough Lidocaine Randomized Controlled Trial Visual Analog Scale Topical Anesthesia Flexible Bronchoscopy
Conditions
Interventions
Participants will receive 2 to 3 puffs of 4 percent lignocaine spray via the bronchoscope for cough suppression during bronchoscopy. The spray will be applied to the oropharynx before the procedure. A
Active Comparator Drug,Active Comparator Drug
4% Lignocaine Spray,10% Lignocaine Spray
Sponsors
Pakistan Emirates Military Hospital, Rawalpindi, Pakistan
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years and above. 2. Patients scheduled for elective flexible bronchoscopy. 3. Patients who provide written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with known hypersensitivity or allergy to lignocaine. 2. Patients with severe hypoxia requiring urgent bronchoscopy. Patients with unstable hemodynamic status. 3. Patients with severe cardiac arrhythmias. 4. Pregnant women. 5. Patients who are unable to provide informed consent. 6. Patients above 60 years of age.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough Severity Immediately after completion of flexible bronchoscopy Visual Analogue Scale from 0 to 10, where 0 indicates no cough and 10 indicates worst possible cough | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Tolerance Immediately after completion of flexible bronchoscopy Visual Analogue Scale from 0 to 10, where 0 indicates very poor tolerance and 10 indicates excellent tolerance | — |
Countries
Pakistan
Contacts
Public ContactHaseeb Lodhi
National University of Medical Sciences
Outcome results
None listed